Access to Medicine Archives

Insulatard and NovoRapid insulin pens used in diabetes treatment.

Weight-Loss Drug Boom Raises New Concerns Over Global Insulin Access

ABE Editorial Desk29 minutes ago4 hours ago07 mins

A new Access to Medicine Foundation assessment warns that growing investment in weight-loss medicines could place additional pressure on insulin access in lower-income countries.

Read Full News

Weight-Loss Drug Boom Raises New Concerns Over Global Insulin Access

Africa’s Luxury Tourism Industry Is Entering a New Era

The Billionaire Family Behind C&A Appoints an Outsider to Lead Its €40 Billion Investment Empire

Germany’s €6.6 Billion KNDS Investment Signals a New Era for Europe’s Defence Industry

Saudi Arabia’s Sovereign Wealth Fund Explores New Financing Strategies as Pressure Grows to Deliver Returns

Global Trade Faces a New Turning Point as China Extends U.S. Tariff Truce and Supply Chains Adjust

Bank of Canada Faces Difficult Interest Rate Decisions as Inflation Persists and Employment Weakens

Canada’s 2026 Federal Budget Sets Out an Ambitious Investment Strategy as Trade Pressures Reshape the Economy

The Hidden Financial Risk Behind the Artificial Intelligence Boom: Who Will Pay if the Returns Fall Short?

From a Pandemic Startup to $100 Million in Revenue: How Pliant’s Founders Are Building the Future of Business Payments

Access to Medicine

Weight-Loss Drug Boom Raises New Concerns Over Global Insulin Access